5 Best Immunotherapy Stocks To Buy Now
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) is a clinical-stage biopharmaceutical company that discovers and develops therapies for the treatment of Alzheimer’s disease.
Avid Bioservices Inc. (CDMO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | BlueCrest Capital Mgmt. Michael Platt And William Reeves | 0 | $0 | 0% | |
| 2. | AQR Capital Management Cliff Asness | 0 | $0 | 0% | |
| 3. | PDT Partners Peter Muller | 0 | $0 | 0% | |
| 4. | Weiss Asset Management Andrew Weiss | 0 | $0 | 0% | |
| 5. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.18 | 126,000 | Director | 126,000 | 2021-03-17 | Filing | |
| $3.22 | 30,000 | Director | 30,000 | 2020-03-23 | Filing | |
| $3.77 | 6,500 | Officer | 12,482 | 2020-03-16 | Filing | |
| $3.75 | 1,000 | Officer | 5,982 | 2020-03-16 | Filing | |
| $3.99 | 12,500 | Officer, Director | 22,500 | 2020-03-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.90 | 1,262 | Officer | 47,020 | 2022-10-10 | Filing | |
| $17.90 | 7,493 | Officer, Director | 76,615 | 2022-10-10 | Filing | |
| $19.15 | 1,365 | Director | 36,881 | 2022-10-03 | Filing | |
| $18.16 | 3,635 | Director | 36,881 | 2022-10-03 | Filing | |
| $17.07 | 334 | Director | 36,881 | 2022-09-01 | Filing |
Institutional Investors' Holdings
News See All
Top 5 Stock Picks of Touk Sinantha's AltraVue Capital
In this article, we will discuss Top 5 Stock Picks of Touk Sinantha's AltraVue Capital.
Is Avid Bioservices (CDMO) a Worthy Investment Pick?
Laughing Water Capital, an investment management firm, published its second-quarter 2022 investor letter – a copy of which can be downloaded here.
Is Avid Bioservices (CDMO) A Smart Long-Term Buy?
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Small Cap Fund’ fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Avid Bioservices, Inc. (CDMO) Fell Out Of Favor With Hedge Funds?
In this article we will analyze whether Avid Bioservices, Inc.
10 Stocks Making Headlines After Financial Results
In this article, we will take a look at the 10 stocks making headlines after financial results.
15 Best Stocks to Buy for 2022 According to Analysts
In this article, we discuss the 15 best stocks to buy for 2022 according to analysts.
Here is What Hedge Funds Think About Avid Bioservices, Inc. (CDMO)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Is Avid Bioservices (CDMO) A Great Long-Term Investment?
Laughing Water Capital LP, an investment management firm, published its second quarter 2021 investor letter – a copy of which can be downloaded here.
Hedge Funds Aren't Crazy About Avid Bioservices, Inc. (CDMO) Anymore
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter.
Billionaire Hedge Funds
